Related Experiment Video
Updated: Feb 18, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null
Christian Marx1, Lisa Marx-Blümel2,3, Nora Lindig2,3
1Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.
Abstract:
The sirtuin 1/2 inhibitor tenovin-1 activates p53 and may have potential in the management of cancer. Here, we investigated the responsiveness of Ewing's sarcoma cells to tenovin-1. We examined its effects in two Ewing's sarcoma cell lines with different p53 status, i.e. in p53 wild-type and p53 null cells. Effects were assessed by flow cytometric analyses of cell death, mitochondrial membrane depolarization and reactive oxygen species (ROS) generation, by caspase 3/7 activity measurement, by mRNA expression profiling and by immunoblotting. Tenovin-1 elicited caspase-mediated cell death in p53 wild-type cells, but caspase-independent cell death in p53 null cells. Remarkably, it induced a nonlinear concentration response in the latter: low concentrations of tenovin-1 were much more effective than were higher concentrations. Tenovin-1's effects in p53 null cells involved gene expression changes of Bcl-2 family members, mitochondrial membrane depolarization, nuclear translocation of apoptosis-inducing factor, ROS formation and DNA damage; all these effects followed a bell-shaped pattern. In conclusion, our results provide new insights into tenovin-1's mode of action by demonstrating that it can induce different pathways of cell death.
Insights
Tenovin-1, a sirtuin 1/2 inhibitor, triggers distinct cell death pathways in Ewing sarcoma. It induces caspase-mediated death in p53 wild-type cells and caspase-independent death, with a unique bell-shaped response, in p53 null cells.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sirtuin 1/2 inhibitor tenovin-1 activates p53, showing potential in cancer management.
- Ewing sarcoma is a pediatric bone cancer with limited treatment options.
Purpose of the Study:
- To investigate the response of Ewing sarcoma cells to tenovin-1.
- To compare tenovin-1's effects in p53 wild-type versus p53 null Ewing sarcoma cells.
Main Methods:
- Flow cytometry for cell death, mitochondrial membrane potential, and reactive oxygen species (ROS).
- Caspase 3/7 activity assays, mRNA expression profiling, and immunoblotting.
- Assessment of tenovin-1's dose-response effects in different p53 contexts.
Main Results:
- Tenovin-1 induced caspase-mediated cell death in p53 wild-type Ewing sarcoma cells.
- In p53 null cells, tenovin-1 triggered caspase-independent cell death via apoptosis-inducing factor.
- A nonlinear, bell-shaped dose-response pattern was observed in p53 null cells, with lower concentrations being more effective.
Conclusions:
- Tenovin-1 activates distinct cell death mechanisms dependent on p53 status in Ewing sarcoma.
- The study reveals a novel bell-shaped concentration response for tenovin-1 in p53 null cells.
- Findings offer new insights into tenovin-1's mechanism of action and potential therapeutic applications in cancer.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
14:57Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Negative Regulator Molecules
The Extrinsic Apoptotic Pathway
Replicative Cell Senescence
DNA Damage can Stall the Cell Cycle